"For me, the patient is at the center of everything we do. Healthcare systems also need to evolve from care and provision to restoring people. It's about more than just business models - it's about giving patients their lives back. And that's what we're fighting for. Every day!"
Dr. Carsten Mahrenholz
Founder and CEO, Coldplasmatech GmbH
"For me, the patient is at the forefront of everything we do. Healthcare systems must evolve from care and delivery to restoring people. It's about more than just business models - it's about giving patients their lives back, And that's what we're fighting for. Every day!"
COLDPLASMATECH has developed the first active wound dressing (CPT®patch) for the treatment of chronic wounds using cold physical plasma.
Based on the needs of doctors, nurses and patients, the Coldplasmatech team, together with experts from Europe's leading institution for plasma technology (INP), has developed a medical product that revolutionizes the treatment of wounds that are difficult to heal. The complex technology of cold plasma is now available in an uncomplicated, safe and effective way as a wound dressing for the therapy of chronic wounds (fully automatic and always at the optimum effect).
Supported by
Biology / Chemistry / Economy
Dr. Carsten Mahrenholz is founder and managing director of Coldplasmatech GmbH.
He is a visionary and networker. Driven by the goal to revolutionize the wound market and healthcare systems.
Medicine / Economy / Reimbursement
Tobias Güra is founder and managing director of Coldplasmatech GmbH. He is an expert in reimbursement and health economics. He is responsible for the smooth running of all processes in the company.
